Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

A genetic mutation in the SGK3 gene causes hairlessness in Scottish Deerhounds and may relate to human hair loss.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

M30 is a promising treatment for preventing hair loss during chemotherapy.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

CTE and FPHL are different hair loss types with unique causes.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Combining MSM with MAP significantly promotes hair growth.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

CD2 might be a new treatment target for patchy alopecia areata.

Biotin helps regulate proteins in the blood, which may explain its role in hair growth.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

ILC1 cells contribute to hair loss in alopecia areata.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.